2
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Chemokines in chronic progressive neurological diseases: HTLV-1 associated myelopathy and multiple sclerosis

, &
Pages 102-108 | Received 04 Sep 1998, Accepted 25 Sep 1998, Published online: 10 Jul 2009

References

  • Arai M, Ohashi T, Tuskahara T, Murakami T, Hori T, Uchiyama T, Yamamoto N, Kannagi M, Fujii M. Human T-cell leukemia virus type 1 TAx protein induces the expression of lymphocyte che-moattractant SDF-1/PBSF. Virology 1998; 241: 298–303
  • Baba M, Imai T, Yoshida T, Yoshie O. Constitutive expression of various chemokine genes in human Th-0 cell lines infected with human T-cell leukemia virus type 1, role of the viral transactivator Tax. Int J Cancer 1996; 66: 124–129
  • Bennetts B H, Teutsch S M, Buhler M M, Heard R N, Stewart Gf. The CCR-5 deletion mutation fails to protect against multiple sclerosis. Human Immunol 1997; 58: 52–59
  • Berman J, Guida M, Warren J, Amat J, Bronsan C. Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. J Immunol 1996; 156: 3017–3023
  • Biddison W, Cruikshank W, Center D, Pelfrey C, Taub D, Turner R. CD8+ Myelin Peptide-Specific T cells can chemoattract CD4+ Myelin Peptide-Specific T cells: Importance of IFN.-Inducible Protein 10. The J Immunol 1998; 160: 444–448
  • Biddison W E, Kubota R, Kawanishi T, Taub D D, Cruikshank W W, Center D M, Connor E W, Utz U, Jacobson S. Human T cell leukemia virus type I (HTLV.-I)-specific CD8+ CTL clones from patients with HTLV.-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase. J Immunol 1997a; 159: 2018–2025
  • Biddison W E, Taub D D, Cruikshank W W, Center D M, Connor E W, Honma K. Chemokine and matrix metalloproteinase secretion by myelin proteolipid protein-specific CD8+ T cells. The J Immunol 1997b; 158: 3046–3053
  • Calabresi P A, Pelfrey C M, Tranquill L R, McFarland H F. VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon beta. Neurology 1997; 49: 1111–1116
  • Caserta M T, Breese Hall C. Human Herpes Virus-6. Ann Rev Med 1993; 44: 377–383
  • Challoner P, Smith K T, Parker J D, MacLeod D L, Coulter S N, Rose T M, Schulz J, Bennett J L, Garber R L, Chang M, Schad P A, Stewart P M, Nowinski R C, Brown J P, Burmer G C. Plaque associated expression of human herpes virus 6 in multiple sclerosis. Proc Natl Acad Sci 1995; 92: 7440–7444
  • Dragic T, Litwin V, Allaway G P, Martin S R, Huang Y, Nagashima K A, Cayanan C, Maddon P J, Koup R A, Moore J P, Paxton W A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC.-CKR-5. Nature 1996; 381: 667–673
  • Ebnet K, Brown K, Siebenlist U, Simon M, Shaw S. Borrelia burgdorferi activates nuclear factor-Kb and is a potent inducer of chemokine and adhesion molecule gene expression in endothelial cells and fibroblasts. J Immunol 1997; 158: 3285–3292
  • Ensoli B, Sturzl M. Kaposi's Sarcoma: A result of the Interplay among Inflammatory Cytokines, Angiogenic Factors and Viral Agents. Cytokine and Growth Factors Rev 1998; 9: 63–83
  • Fox R J, Levin M C, Jacobson S. TNF alpha expression in the spinal cord of HAM/TSP patients. J Neurovirol 1996; 2: 323–329
  • Glabinski A, Tani M, Strieter R, Tuohy V, Ransohoff R. Synchronous synthesis of alpha and beta chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am J Pathol 1997; 150: 617–630
  • Glabinski A R, Tani M, Tuohy V H, Tuthill R J, Ransohoff R M. Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis. Rrain Behav Immunol 1995; 9: 315–330
  • Godiska R, Chantry D, Dietsch G N, Gray P W. Chemokine expression in murine experimental allergic encephalomyelitis. J Neuroimmunol 1995; 58: 167–176
  • Gompels U, Nicholas J, Lawrence G, et al. The DNA sequence of human herpes virus-6: structure, coding content, and genome evolution. Virology 1995; 209: 29–51
  • Gupta S, Lysko P, Pillarisetti K, Ohlstein E, Stadel J. Chemokine Receptors in Human Endothelial Cells. J Biol Chem 1998; 273: 4282–4287
  • Hemmer B, Vergelli M, Calabresi P A, Huang T, McFar-Land H, Martin R. Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin protein peptide. J Neurol Sci 1996; 45: 852–862
  • Hogancamp W, Rodriguez M, Weinshenker B G. The Epidemiology of Multiple Sclerosis. Mayo Clin Proc 1997; 72: 871–878
  • Hollberg P, Hafler D A. Pathogenesis of disease induced by HTLV-1 infection. N Engl J Med 1993; 328: 1173–1182
  • Kelly M D, Hassan M N, Adams S L, Cunningham A L, Lloyd A R. Cutting Edge: Dichotomus Effects of β-Chemokines on HIV Replication in Monocytes and Monocyte-Derived Macrophages. J Immunol 1998; 160: 3091–3095
  • Lehky T J, Fox C H, Levin M C, Flerlage N, Izumo S, Sato E, Raine C S, Osame M, Jacobson S. Detection of HTLV-1Tax RNA in the CNS of HAM/TSP patients by in situ hybridization. Ann Neurol 1995; 47: 167–175
  • Leppert D, Waubant E, Galardy R, Bunnett N W, Hauser S L. T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 1995; 154: 4379–4389
  • Lovett-Racke A E, Trotter J L, Lauber J, Perrin P J, June C H, Racke M K. Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients: a marker of activated/memory T cells. J Clin Inv 1998; 101: 725–730
  • Lucchinetti C F, Rodriguez M. The controversy surrounding the pathogenesis of the multiple sclerosis lesion. Mayo Clin Proc 1997; 72: 665–678
  • Luster A D. Chemokines-Chemotactic Cytokines That Mediate Inflammation. JV. Engl J Med 1998; 338: 436–445
  • Martin R, McFarland H F. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci 1995; 32: 121–182
  • McFarland H F, Greenstein F, McFarlin D E, et al. Family and twin studies in multiple sclerosis. Ann NY Acad Sci 1985; 436: 118–124
  • Meini E, Fickenscher H, Fleckenstein B. Chemokine receptors and chemokine-inducing molecules of lymphotrophic herpes viruses. Immunol Today 1996; 17: 198
  • Mendez E, Kawanashi T, Clemens K, Siomo H, Calabresi P A, Brady J, Jacobson J. Astrocyte Specific Expression of Human T.-Cell Lymphotrophic Type I (HTLV-1) Tax: Induction of TNF alpha and Susceptibility to Lysis by CD8+ HTLV-1 Specific Cytotoxic T Cells. J Virology 1997; 71: 9143–9149
  • Merrill J E, Benveniste E N. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci 1996; 19: 331–338
  • Merrill J E, Murphy S P. Inflammatory events at the blood brain barrier: regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species. Brain Behav Immunol 1997; 11: 245–263
  • Nakagawa M, Izumo S, Ijichi S, Kubota H, Arimura K, Kawabata M, Osame M. HTLV-1 associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol 1995; 1: 50–61
  • Qin S, Rottman J B, Myers P, Kassam N, Weinblatt M, Loetscher M, Koch A E, Moser B, Mackay C R. The Chemokine Receptors CXCR3 and CCR5 Mark Subsets of T Cells Associated with Certain Inflammatory Reactions. J Clin Invest 1998; 101: 746–754
  • Raine C S. Multiple Sclerosis: Immune system molecule expression in the central nervous system. J Neuropathol Exp Neurol 1994; 53: 328–337
  • Ransohoff R M, Glabinski A, Tani M. Chemokines in immune-mediated inflammation of the central nervous system. Cytokine & Growth Factor Rev 1996; 7: 35–46
  • Rieckmann P, Albrecht M, Kitze B, Weber T, Tumani H, Broocks A, Luer W, Helwig A, Poser S. Tumor necrosis factor-α mRNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann Neurol 1995; 37: 82–88
  • Sallusto F, Lenig D, McKay C R, Lanzavecchia A. Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes. J Exp Med 1998; 187: 875–883
  • Schall T. The Chemokines. The Cytokine Handbook. Academic Press, London 1994; 419–460
  • Simpson J E, Newcombe J, Cuzner M L, Woodroofe M N. Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J Neuroimmunol 1998; 84: 238–249
  • Smith G L. Virus proteins that bind cytokines, chemokines or interferons. Curr Opin Immunol 1996; 8: 467–471
  • Soldan S, Bert R, Salem N, Secchiero P, Calabresi P A, Maloni H, McFarland H F, Lin H C, Patnaik M, Jacobson S. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nature Med 1997; 3: 1394–1397
  • Stuve O, Chabot S, Jung S S, Williams G, Wee Yong V. Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-lb through an effect on matrix metalloproteinase-9. J Neuroimmunol 1997; 80: 38–46
  • Stuve O, Dooley N P, Uhm J H, Antel J P, Francis G S, Williams G, Wee Yong V. Interferon β-1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase-9. Ann Neurol 1996; 40: 853–863
  • Tanaka Y, Mine S, Figdor C, Wake A, Hirano H, Tsudada J, Aso M, Fujii K, Saito K, Van Kooyk Y, Eto S. Constitutive chemokine production results in activation of leukocyte function-associated antigen-1 on adult T-cell leukemia cells. Blood 1998; 91: 3909–3919
  • Taub D. Chemokine-Leukocyte Interactions. Cytokine and Growth Factor Rev 1996; 7: 355–376
  • Umehara F, Izumo S, Takeya M, Takahashi K, Sato E, Osame M. Expression of adhesion molecules and monocyte chemoattractant protein-1 (MCP-1) in the spinal cord lesions in HTLV.-I-associated myelopathy. Acta Neuropathol (Bed) 1996; 91: 343–350
  • Zou Y, Kottmann A, Kuroda M, Taniuchi I, Littman D. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998; 393: 595–599

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.